2023 Grover Conference

2023 格罗弗会议

• 批准号: 10753743
• 负责人: Anna R Hemnes
• 金额: $ 1万
• 依托单位: VANDERBILT UNIVERSITY MEDICAL CENTER
• 依托单位国家: 美国
• 财政年份: 2023
• 资助国家: 美国
• 起止时间: 2023-08-01 至 2024-07-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10753743
• 关键词: Address; American; Animal Model; Animal Organ; Bioethics; Biology; Blood Vessels; Calendar; Cardiopulmonary; Caregivers; Cell Proliferation; Cells; Cellular biology; Clinic; Clinical; Clinical Medicine; Data; Data Analyses; Development; Diagnosis; Disease; Environment; Epigenetic Process; Faculty; Functional disorder; Funding; Future; Genes; Genetic; Genomics; Health; Inflammatory; International; Knowledge; Leadership; Lung; Medical Records; Mission; Molecular; Names; National Heart, Lung, and Blood Institute; North America; Outcome; Phenotype; Postdoctoral Fellow; Proteomics; Pulmonary Heart Disease; Pulmonary Hypertension; Research; Research Personnel; Right Ventricular Dysfunction; Right ventricular structure; Role; Science; Scientist; Signal Transduction; Stress; Students; Systems Biology; Techniques; Technology; Time; United States National Institutes of Health; biomarker discovery; chronic thromboembolic pulmonary hypertension; clinical trial analysis; design; drug discovery; improved; interest; meetings; metabolomics; next generation sequencing; organ on a chip; personalized care; posters; precision medicine; programs; pulmonary arterial hypertension; pulmonary vascular disorder; right ventricular failure; rural setting; senior faculty; symposium; tool

The Grover Conference, which is usually held every two years, is the only international meeting in North America that repeatedly focuses on subjects relevant to lung vascular biology, the right ventricle and clinical medicine. Initiated in 1984 under the leadership of the late Dr. John T. “Jack” Reeves, and named in honor of Dr. Robert Grover, the Conference is held in a secluded, rural setting in the Rocky Mountains. The Conference has been continuously refined and refocused in each of the subsequent iterations to include emerging topics such as vascular cell proliferation and biology, lung vascular development, proinflammatory signaling in the pulmonary vasculature, vascular channelopathies, and most recent right ventricular dysfunction in pulmonary vascular disease. The majority of recent Grover Conferences were supported at least in part by the NIH NHLBI R13 funding program. This meeting is unique, because it will bring together scientists interested in precision medicine approaches to pulmonary vascular disease and right heart failure in an environment conducive to interaction and the exchange of ideas among junior and senior investigators and students. In the 2023 calendar year, this will be the only North American conference that will focus completely on the biology of the cardiopulmonary unit. We also believe this meeting is timely and impactful because it will focus on molecular mechanisms and systems biology in the context of understanding cardiopulmonary diseases. We propose a Conference focused on a wide array of genetic, genomic, epigenetic, and related factors relevant to the pathophysiology of pulmonary hypertension and the adaptation of the right ventricle to the stress of pulmonary hypertension. Cutting edge technologies, such as state-of-the-art next generation sequencing techniques and data analysis are included to educate and expand the quickening pace of exciting research in this growing field. Importantly, our proposed agenda includes speakers from highly diverse backgrounds and incorporates junior trainees throughout.

格罗弗会议通常每两年举行一次，是唯一的国际会议 在北美，反复关注与肺血管生物学相关的主题的右翼 脑室和临床医学。1984年在已故约翰·T博士的领导下发起 “杰克”·里夫斯，并以罗伯特·格罗弗博士的名字命名，会议在一个隐蔽的， 落基山脉的乡村背景。会议不断得到完善和完善 在随后的每一次迭代中重新聚焦，以包括新出现的主题，如血管细胞 增殖与生物学、肺血管发育、促炎信号转导 肺血管系统、血管通道病变和最近的右心功能不全 在肺血管疾病中。最近格罗弗会议的大多数会议都得到了 至少部分是由NIH NHLBI R13资助计划提供的。这次会议是独一无二的，因为它将 将对肺血管精确医学方法感兴趣的科学家聚集在一起 疾病和右心衰竭在有利于互动和交流的环境中 初级和高级调查人员和学生中的想法。在2023年，这将是 这是唯一一次完全聚焦于生物的北美会议 心肺单元。我们还认为，这次会议是及时和有影响的，因为它将集中 理解语境中的分子机制与系统生物学 心肺疾病。我们建议召开一次会议，重点讨论广泛的基因、 与肺脏病理生理学相关的基因组、表观遗传学及相关因素 高血压和右心室对肺动脉高压应激的适应。 尖端技术，如最先进的下一代测序技术和 包括数据分析，以教育和扩大令人兴奋的研究的加速步伐 这个不断增长的领域。重要的是，我们提议的议程包括来自高度不同的发言者 背景，并在整个过程中纳入初级实习生。